Middle East Conflict Threatens Indian Pharma Exports with Potential Rs 5,000 Crore Loss

India's pharmaceutical exports face potential disruptions and losses of Rs 2,500-5,000 crore due to the ongoing conflict in the Middle East. Key shipping routes like the Red Sea and Suez Canal are at risk, causing longer transit times and increased freight costs. The Gulf Cooperation Council (GCC) and West Asia-North Africa (WANA) regions, significant markets for Indian medicines, may experience delays affecting supply chains, especially for temperature-sensitive products. Industry bodies urge government collaboration to mitigate impacts through freight relief and alternative logistics.